341 related articles for article (PubMed ID: 29445985)
41. Outcomes following cryoballoon ablation for atrial fibrillation guided by pressure waveform monitoring without the routine use of pulmonary venography.
Sharma A; Dhoot J; Wang J; Jones P; Gupta S; Wimmer AP
J Interv Card Electrophysiol; 2017 Jun; 49(1):75-82. PubMed ID: 28374072
[TBL] [Abstract][Full Text] [Related]
42. Incidence of real-time recordings of pulmonary vein potentials using the third-generation short-tip cryoballoon.
Chierchia GB; Mugnai G; Ströker E; Velagic V; Hünük B; Moran D; Hacioglu E; Poelaert J; Verborgh C; Umbrain V; Beckers S; Ruggiero D; Brugada P; de Asmundis C
Europace; 2016 Aug; 18(8):1158-63. PubMed ID: 26857185
[TBL] [Abstract][Full Text] [Related]
43. Regular atrial tachycardias developing after cryoballoon pulmonary vein isolation: incidence, characteristics, and predictors.
Mikhaylov EN; Bhagwandien R; Janse PA; Theuns DA; Szili-Torok T
Europace; 2013 Dec; 15(12):1710-7. PubMed ID: 23689485
[TBL] [Abstract][Full Text] [Related]
44. Impact of the order of the targeted pulmonary vein on the vagal response during second-generation cryoballoon ablation.
Miyazaki S; Nakamura H; Taniguchi H; Hachiya H; Ichihara N; Takagi T; Iwasawa J; Kuroi A; Watanabe T; Hirao K; Iesaka Y
Heart Rhythm; 2016 May; 13(5):1010-1017. PubMed ID: 26711797
[TBL] [Abstract][Full Text] [Related]
45. A comparison of acute procedural outcomes within four generations of cryoballoon catheters utilized in the real-world multicenter experience of 1STOP.
Iacopino S; Pieragnoli P; Arena G; Sciarra L; Landolina M; Manfrin M; Verlato R; Solimene F; Sacchi R; Rebellato L; Rovaris G; Molon G; Infusino T; Tondo C
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):80-88. PubMed ID: 31701569
[TBL] [Abstract][Full Text] [Related]
46. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
[TBL] [Abstract][Full Text] [Related]
47. Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.
Casado-Arroyo R; Chierchia GB; Conte G; Levinstein M; Sieira J; Rodriguez-Mañero M; di Giovanni G; Baltogiannis Y; Wauters K; de Asmundis C; Sarkozy A; Brugada P
Heart Rhythm; 2013 Sep; 10(9):1318-24. PubMed ID: 23891574
[TBL] [Abstract][Full Text] [Related]
48. Clinical recurrence and electrical pulmonary vein reconnections after second-generation cryoballoon ablation.
Miyazaki S; Taniguchi H; Hachiya H; Nakamura H; Takagi T; Hirao K; Iesaka Y
Heart Rhythm; 2016 Sep; 13(9):1852-7. PubMed ID: 27241352
[TBL] [Abstract][Full Text] [Related]
49. Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci.
Yanagisawa S; Inden Y; Kato H; Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Ando M; Hirai M; Shibata R; Murohara T
J Cardiol; 2017 Jan; 69(1):3-10. PubMed ID: 27499270
[TBL] [Abstract][Full Text] [Related]
50. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.
Packer DL; Kowal RC; Wheelan KR; Irwin JM; Champagne J; Guerra PG; Dubuc M; Reddy V; Nelson L; Holcomb RG; Lehmann JW; Ruskin JN;
J Am Coll Cardiol; 2013 Apr; 61(16):1713-23. PubMed ID: 23500312
[TBL] [Abstract][Full Text] [Related]
51. Single freeze strategy with the second- generation cryballoon for atrial fibrillation: a multicenter international retrospective analysis in a large cohort of patients.
De Regibus V; Iacopino S; Abugattas JP; Coutiño HE; Mugnai G; Storti C; Conte G; Auricchio A; Moran D; Ströker E; Marroquin L; Takarada K; Choudhury R; de Asmundis C; Brugada P; Chierchia GB
J Interv Card Electrophysiol; 2017 Aug; 49(2):173-180. PubMed ID: 28573498
[TBL] [Abstract][Full Text] [Related]
52. Adenosine testing during cryoballoon ablation and radiofrequency ablation of atrial fibrillation: A propensity score-matched analysis.
Tokuda M; Matsuo S; Isogai R; Uno G; Tokutake K; Yokoyama K; Kato M; Narui R; Tanigawa S; Yamashita S; Inada K; Yoshimura M; Yamane T
Heart Rhythm; 2016 Nov; 13(11):2128-2134. PubMed ID: 27520540
[TBL] [Abstract][Full Text] [Related]
53. Second generation cryoballoon ablation for atrial fibrillation in young adults: midterm outcome in patients under 40 years of age.
Moran D; De Regibus V; de Asmundis C; Takarada K; Mugnai G; Ströker E; Aryana A; Iacopino S; Ruggiero D; Coutiño-Moreno HE; Choudhury R; Abugattas JP; Hacioglu E; Paparella G; Brugada P; Chierchia GB
Europace; 2018 Feb; 20(2):295-300. PubMed ID: 28122804
[TBL] [Abstract][Full Text] [Related]
54. Individualized or fixed approach to pulmonary vein isolation utilizing the fourth-generation cryoballoon in patients with paroxysmal atrial fibrillation: the randomized INDI-FREEZE trial.
Heeger CH; Popescu SS; Saraei R; Kirstein B; Hatahet S; Samara O; Traub A; Fehe M; D'Ambrosio G; Keelani A; Schlüter M; Eitel C; Vogler J; Kuck KH; Tilz RR
Europace; 2022 Jul; 24(6):921-927. PubMed ID: 34907431
[TBL] [Abstract][Full Text] [Related]
55. Impact of 3D mapping on procedural characteristics and outcomes in cryoballoon pulmonary vein isolation for atrial fibrillation.
Guhl EN; Adelstein E; Voigt A; Wang NC; Saba S; Jain SK
J Interv Card Electrophysiol; 2018 Jan; 51(1):71-75. PubMed ID: 29305676
[TBL] [Abstract][Full Text] [Related]
56. Two-year outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon: lessons from the bonus freeze protocol.
Metzner A; Heeger CH; Wohlmuth P; Reißmann B; Rillig A; Tilz RR; Mathew S; Lemes C; Deiß S; Maurer T; Saguner A; Ouyang F; Kuck KH; Wißner E
Clin Res Cardiol; 2016 Jan; 105(1):72-8. PubMed ID: 26164844
[TBL] [Abstract][Full Text] [Related]
57. Two versus one repeat freeze-thaw cycle(s) after cryoballoon pulmonary vein isolation: the alster extra pilot study.
Chun KR; Fürnkranz A; Köster I; Metzner A; Tönnis T; Wohlmuth P; Wissner E; Schmidt B; Ouyang F; Kuck KH
J Cardiovasc Electrophysiol; 2012 Aug; 23(8):814-9. PubMed ID: 22487260
[TBL] [Abstract][Full Text] [Related]
58. Comparison of pulmonary vein isolation using cryoballoon versus conventional radiofrequency for paroxysmal atrial fibrillation.
Mugnai G; Chierchia GB; de Asmundis C; Sieira-Moret J; Conte G; Capulzini L; Wauters K; Rodriguez-Mañero M; Di Giovanni G; Baltogiannis G; Ciconte G; Saitoh Y; Juliá J; Brugada P
Am J Cardiol; 2014 May; 113(9):1509-13. PubMed ID: 24630388
[TBL] [Abstract][Full Text] [Related]
59. Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial.
Chun KR; Stich M; Fürnkranz A; Bordignon S; Perrotta L; Dugo D; Bologna F; Schmidt B
Heart Rhythm; 2017 Apr; 14(4):495-500. PubMed ID: 27956248
[TBL] [Abstract][Full Text] [Related]
60. Mesh ablator vs. cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: results of the MACPAF study.
Koch L; Haeusler KG; Herm J; Safak E; Fischer R; Malzahn U; Werncke T; Heuschmann PU; Endres M; Fiebach JB; Schultheiss HP; Schirdewan A
Europace; 2012 Oct; 14(10):1441-9. PubMed ID: 22523379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
